Effects of calcium antagonists on binding of local anesthetics to plasma proteins and erythrocytes in mice

Pharmacology

Volumn 53, Issue 4, 1996, Pages 219-223

  Jacob, Dominique ^a   Grignon, Sylvain ^a   Attolini, Laurence ^a   Gantenbein, Manon ^a   Bruguerolle, Bernard ^a  

^a Faculté de Médecine de Marseille   (France)

Author keywords

Bupivacaine; Calcium channel blockers; Diltiazem; Lidocaine; Local anesthetics; Nicardipine; Pharmacokinetics; Verapamil

Indexed keywords

BUPIVACAINE; CALCIUM ANTAGONIST; DILTIAZEM; DRUG METABOLITE; LIDOCAINE; LOCAL ANESTHETIC AGENT; NICARDIPINE; PLASMA PROTEIN; VERAPAMIL;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG PROTEIN BINDING; ERYTHROCYTE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL;

EID: 0029822340     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139433     Document Type: Article

References (13)

1. Pucilowski O: Psychopharmacologi-cal properties of calcium channel inhibitors, Psychopharmacology 1992; 109:12-29.
2. Schlanz KD, Myre SA, Bottorff M B: Pharmacokinetic interactions with calcium channel antagonists, Part I, Clin Pharmacokinet 1991;21:344-356.
3. Schlanz KD, Myre SA, Bottorl TMB: Pharmacokinetic interactions with calcium channel antgonists, Part II, Clin Pharmacokinet 1991;21:448-460.
4. Bruguerollc B: Effects of calcium channel blockers on bupivacaine-in-duced toxicity, Life Sci I993;53: 349-353.
5. Bruguerolle B, Lorec AM: Bupiva-cainc kinetic changes induced by diltiazem in mice, Life Sci 1994:54: 315-319.
6. Bjork M, Pctterson KJ, Osterlof G: Capillary gas chromatographic method for the simultaneous determination of local anesthetics in plasma samples, J Chromatogr 1990: 533:229-324.
7. Lorec AM, Bruguerolle B, Attolini L, Roucoules X: Rapid simultaneous determination of lidocainc, bupivacainc and their two main metabolites using capillary gas liquid chromatography with nitrogen phosphorus detector, Thcr Drug Monit 1994;16:592-595.
8. Bruguerolle B, Jadot J, Valli M, Bouyard L, Zemmour C, Mouchet J, Bouvard P: A propos de la determination de la fraction libre des médicaments, Thérapie I982;35:554-555.
9. Tucker GT, Mather LE: Clinical pharmacokinetics of local anaesthetics, Clin Pharmacokinet 1979:4: 241-278.
10. Koleva MR, Stoychev TS: Liver monooxvgenase activity after multiple application of nifedipine, verapamil and diltiazem, Acta Physiol Pharmacol Bulg 1990;16:16-22.
11. Echizcn H, Eichelbaunt M: Clinical pharmacokinetics of verapamil, nifedipine and diltiazem, Clin Pharmacokinet 1986; 11:425-449.
12. Gohel TJ, Davenport JB, Stanley MJ: Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey, Xenobioti-ca 1973:3:761-772.
13. Bruguerolle B, Attolini L, Gantcn-bein M: Acute toxicity of bupivacaine metabolites in mice, Clin Exp Pharmacol 1994:21:997-999.